Enter assignee name

Trademarks = 1

Forward Citations = 8

Loading Chart...

19 inventors (with patents filed for the assignee):

Philip Ma (4 out of 5 patents)

Bruce Wilcox (4 out of 4 patents)

John E Blume (3 out of 24 patents)

4. Mi Yang (3 out of 3 patents)

5. Asim Siddiqui (2 out of 4 patents)

6. Omid C Farokhzad (2 out of 75 patents)

7. William C Manning, Jr (2 out of 3 patents)

8. Gregory Troiano (2 out of 6 patents)

9. Manway Liu (2 out of 2 patents)

10. Chinmay Belthangady (2 out of 3 patents)

11. Preston B Williams (2 out of 3 patents)

12. Jared Deyarmin (2 out of 2 patents)

13. Kavya Swaminathan (2 out of 2 patents)

14. Francois Collin (1 out of 4 patents)

15. Robert Samuel Langer (1 out of 636 patents)

6 patents: Sort by Forward Citations

1. 12504432 - Enhanced detection and quantitation of biomolecules (2025-12-23),

2. 12387508 - Direct classification of raw biomolecule measurement data (2025-08-12),

3. 12334190 - Multi-omic assessment using proteins and nucleic acids (2025-06-17),

4. 12087405 - Methods of processing a biofluid sample (2024-09-10),

5. 12007397 - Enhanced detection and quantitation of biomolecules (2024-06-11),

6. 11664092 - Lung biomarkers and methods of use thereof (2023-05-30),

Prognomiq, Inc. is a biotechnology company focused on transforming healthcare through advanced genomic and proteomic technologies. By leveraging cutting-edge data analytics and machine learning, Prognomiq aims to provide personalized insights that enhance patient care and improve clinical outcomes. Their innovative platform integrates multi-omics data to enable early disease detection and tailored treatment strategies, ultimately driving precision medicine forward. With a commitment to research and collaboration, Prognomiq partners with leading institutions to advance the understanding of complex diseases and develop novel therapeutic approaches.

Profile summary based on public USPTO records.